Form 4: RxSight Officer Scott Gaines Reports Stock Transactions

RxSight Chief Customer Officer Scott Gaines reported recent acquisitions and dispositions of common stock and restricted stock units, including new RSU grants and vesting events.

Summary

• Scott Gaines, Chief Customer Officer of RxSight, Inc. (RXST), reported transactions involving the company's common stock and restricted stock units (RSUs).
• On February 28, 2026, Gaines acquired 6,261 shares of common stock and disposed of 2,580 shares at a price of $7.61 per share, resulting in a beneficial ownership of 14,848 direct shares.
• On February 27, 2026, Gaines was granted 32,218 new RSUs, which are scheduled to vest in six equal installments on August 31, 2026, February 28, 2027, August 31, 2027, February 28, 2028, August 31, 2028, and February 28, 2029.
• Several existing RSU awards also matured on February 28, 2026, leading to the acquisition of 1,500, 604, 1,250, 1,657, and 1,250 shares of common stock from previously granted RSUs.
• All reported transactions were made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged trading strategy.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing. The RSU grants and vesting are routine executive compensation, aligning management with long-term performance, while the stock disposition is likely for tax purposes.

Positives

• The grant of 32,218 new Restricted Stock Units (RSUs) to the Chief Customer Officer indicates continued long-term incentive alignment with company performance and executive retention.
• The vesting of multiple RSU awards demonstrates ongoing compensation and retention of a key executive, reinforcing their commitment to the company.

Negatives

• The disposition of 2,580 shares of common stock at $7.61, likely for tax withholding purposes upon RSU vesting, reduces the executive's direct share ownership.

Future Outlook

The vesting schedules for the Restricted Stock Units extend through February 2029, indicating a long-term incentive structure for the Chief Customer Officer tied to future company performance and continued service.

Industry Context

StockSavvy.ai notes that the use of Restricted Stock Units (RSUs) as a significant component of executive compensation is a common practice across various industries, particularly in technology and growth-oriented companies like RxSight. This approach aligns executive incentives with long-term shareholder value creation and retention. The Rule 10b5-1 plan indicates a pre-arranged trading strategy, which is standard for insiders to avoid accusations of trading on material non-public information.

Comparison to Industry Standards

• StockSavvy.ai observes that the RSU grants and vesting schedules are consistent with typical executive compensation packages in the medical technology sector.
• Companies such as Alcon (ALC) and Bausch + Lomb (BLCO) frequently utilize similar equity-based incentives to retain key talent and align management interests with long-term corporate objectives.
• The disposition of shares for tax withholding is a standard practice upon RSU vesting, comparable to how executives at companies like Johnson & Johnson (JNJ) or Medtronic (MDT) manage their equity compensation.

Corporate Governance

Related Party Transactions

• Acquisition and disposition of company common stock and restricted stock units by Scott Gaines, Chief Customer Officer, are considered related party transactions as they involve an insider of RxSight, Inc.

Stakeholder Impact

• Shareholders: The RSU grants and vesting align the Chief Customer Officer's interests with long-term shareholder value. The disposition for tax purposes is a routine event and not indicative of a lack of confidence.
• Employees: The equity compensation structure for a key executive may serve as a model or benchmark for other employee incentive programs.

Next Steps

• Continued vesting of 32,218 RSUs in six equal installments on August 31, 2026, February 28, 2027, August 31, 2027, February 28, 2028, August 31, 2028, and February 28, 2029.
• Further vesting of other RSU awards according to their respective schedules through February 28, 2029, contingent on Scott Gaines remaining a Service Provider.

Key Dates

Recommendation

The filing details routine insider transactions related to executive compensation and tax withholding, executed under a pre-arranged 10b5-1 plan. These transactions do not provide new material information about the company's operational performance or strategic direction that would warrant a change in investment thesis. The continued RSU grants suggest ongoing executive alignment with long-term company goals. Therefore, a 'hold' recommendation is appropriate as there's no new catalyst for a 'buy' or 'sell' decision based solely on this Form 4.

Keywords

RxSight, RXST, Scott Gaines, Chief Customer Officer, SEC Form 4, Insider Trading, Stock Transaction, Restricted Stock Units, RSU, Equity Compensation, Stock Ownership, Rule 10b5-1